A paratyphoid fever combined vaccine (Lanzhou institute of biological products)

甲型副伤寒结合疫苗（兰州生物制品）

Report date: 2022/01/17 12:14:22

Base Information

Drug NameA paratyphoid fever combined vaccine (Lanzhou institute of biological products)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParatyphoid Fever

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesLanzhou Institute Of Biological Products Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsParatyphoid Fever

Inactive IndicationsN/A

Other Information

ATC CodeN/A